Globally, new cancer cases will rise by 57% within the next two decades, with the majority in the low- and middle-income countries (LMICs). Consequently, a steep increase of about 40% in cancer deaths is expected there, mainly because of lack of treatment facilities, especially radiotherapy. Radiotherapy is required for more than 50% of patients, but the capital cost for equipment often deters establishment of such facilities in LMICs. Presently, of the 139 LMICs, 55 do not even have a radiotherapy facility, whereas the remaining 84 have a deficit of 61.4% of their required radiotherapy units. Networking between centers could enhance the effectiveness and reach of existing radiotherapy in LMICs. A teleradiotherapy network could enable cente...
Introduction: Cancer is the expected leading cause of death in Low and Middle Income Countries (LMIC...
Purpose. The estimated new cancer patient load in the Indian state of Uttar Pradesh is 0.1–0.12 mill...
Radiotherapy is used for cure or palliation in around half of patients with cancer. We analysed data...
PURPOSE: To propose a roadmap and explore the cost implications of establishing a teleradiotherapy n...
AbstractAbout 57% of the total number of cancer cases occur in low and middle income countries. Radi...
More than half of all cancer diagnoses worldwide occur in low- and middle-income countries (LMICs) a...
More than half of all cancer diagnoses worldwide occur in low- and middle-income countries (LMICs) a...
Radiotherapy is a critical and inseparable component of comprehensive cancer treatment and care. For...
Radiotherapy is an essential modality for effective cancer control, yet enormous inequalities in acc...
Radiotherapy is an essential modality for effective cancer control, yet enormous inequalities in acc...
Closing the gap in cancer care within low- and middle-income countries and in indigenous and geograp...
Radiation therapy plays a critical role in the management of breast cancer and often is unavailable ...
Radiotherapy is an essential part of the multimodality treatment of breast cancer. Applying safe and...
Many low- and middle-income countries, together with remote and low socioeconomic populations within...
In developing countries, many centres work in relative isolation with limited access to up-to-date p...
Introduction: Cancer is the expected leading cause of death in Low and Middle Income Countries (LMIC...
Purpose. The estimated new cancer patient load in the Indian state of Uttar Pradesh is 0.1–0.12 mill...
Radiotherapy is used for cure or palliation in around half of patients with cancer. We analysed data...
PURPOSE: To propose a roadmap and explore the cost implications of establishing a teleradiotherapy n...
AbstractAbout 57% of the total number of cancer cases occur in low and middle income countries. Radi...
More than half of all cancer diagnoses worldwide occur in low- and middle-income countries (LMICs) a...
More than half of all cancer diagnoses worldwide occur in low- and middle-income countries (LMICs) a...
Radiotherapy is a critical and inseparable component of comprehensive cancer treatment and care. For...
Radiotherapy is an essential modality for effective cancer control, yet enormous inequalities in acc...
Radiotherapy is an essential modality for effective cancer control, yet enormous inequalities in acc...
Closing the gap in cancer care within low- and middle-income countries and in indigenous and geograp...
Radiation therapy plays a critical role in the management of breast cancer and often is unavailable ...
Radiotherapy is an essential part of the multimodality treatment of breast cancer. Applying safe and...
Many low- and middle-income countries, together with remote and low socioeconomic populations within...
In developing countries, many centres work in relative isolation with limited access to up-to-date p...
Introduction: Cancer is the expected leading cause of death in Low and Middle Income Countries (LMIC...
Purpose. The estimated new cancer patient load in the Indian state of Uttar Pradesh is 0.1–0.12 mill...
Radiotherapy is used for cure or palliation in around half of patients with cancer. We analysed data...